Arcellx, Inc.
USD115.07
+0.02 (+0.02%)
CEO
Rami Elghandour
IPO Date
2022-02-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$115.03
Prev. Close
$115.05
Day Low
$115.03
Day High
$115.07
52W Low
$50.85
52W High
$115.13
Market Cap
$6.73B
Volume
13.19M
| -38.3 |
| 31 Dec 2023 | FY | 100.0% | -64.1% | -14.6% | -8.6% | 0.20 | 6.06 | -37.7 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -92.1% | -60.1% | 0.43 | 4.71 | -7.2 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | 53.5% | -50.4% | 0.00 | 7.60 | -8.7 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -63.5% | -55.6% | 0.00 | 9.36 | -11.4 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 54.9% | -41.2% | 0.00 | 12.53 | -32.5 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -59.5% | -52.5% | 0.00 | 8.06 | -0.3 |
| -20.8 |
| 30 Jun 2025 | Q2 | 100.0% | -698.6% | -13.5% | -8.5% | 0.13 | 3.81 | -17.5 |
| 31 Mar 2025 | Q1 | 100.0% | -766.0% | -14.9% | -9.6% | 0.13 | 4.93 | -14.6 |
| 31 Dec 2024 | Q4 | 100.0% | -308.4% | -10.4% | -6.6% | 0.12 | 4.78 | -21.9 |
| 30 Sept 2024 | Q3 | 100.0% | -99.4% | -5.4% | -3.4% | 0.14 | 4.29 | -43.4 |
| 30 Jun 2024 | Q2 | 95.5% | -99.3% | -5.6% | -3.7% | 0.15 | 6.01 | -26.4 |
| 31 Mar 2024 | Q1 | 97.9% | -18.3% | -1.4% | -0.9% | 0.18 | 5.46 | -122.7 |
| 31 Dec 2023 | Q4 | 98.9% | 31.4% | 4.1% | 2.4% | 0.20 | 6.06 | 36.6 |
| 30 Sept 2023 | Q3 | 97.0% | -263.0% | -14.8% | -6.4% | 0.41 | 2.84 | -11.0 |